Arjun Sarkar

Arjun Sarkar

Auto-generated profile, based on publicly available information

Arjun Sarkar

Feinberg School of Medicine, Northwestern University, Chicago, IL, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Cell Reports
Verified
Journal Article
Open access
JRJessica E. Rexach
Jessica E. Rexach
DPDamon Polioudakis
Damon Polioudakis
AYAnna Yin
Anna Yin
VSVivek Swarup
Vivek Swarup
TCTimothy S. Chang
Timothy S. Chang
Daniel GeschwindDaniel Geschwind
Daniel Geschwind
To understand how neural-immune-associated genes and pathways contribute to neurodegenerative disease pathophysiology, we performed a systematic functional genomic analysis in purified microglia and bulk tissue from mouse and human AD, FTD, and PSP. We uncover a complex temporal trajectory of microglial-immune pathways involving the type 1 interferon response associated with tau pathology in the early stages, followed by later signatures of partial immune suppression and, subsequently, the type 2 interferon response. We find that genetic risk for dementias shows disease-specific patterns of pathway enrichment. We identify drivers of two gene co-expression modules conserved from mouse to human, representing competing arms of microglial-immune activation (NAct) and suppression (NSupp) in neurodegeneration. We validate our findings by using chemogenetics, experimental perturbation data, and single-cell sequencing in post-mortem brains. Our results refine the understanding of stage- and disease-specific microglial responses, implicate microglial viral defense pathways in dementia pathophysiology, and highlight therapeutic windows.

22 September 2022 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
MIMartha-Conley Ingram
Martha-Conley Ingram
SBSasha Becker
Sasha Becker
SOSydney Olson
Sydney Olson
STStacy Tsai
Stacy Tsai
ASArjun Sarkar
Arjun Sarkar
MRMehul V Raval
Mehul V Raval

1 September 2021 in Urology Case Reports
Verified
Journal Article
Open access
ASArjun Sarkar
Arjun Sarkar
MSMohammad Rashid Siddiqui
Mohammad Rashid Siddiqui
RFRichard J. Fantus
Richard J. Fantus
MHMaha Hussain
Maha Hussain
JHJoshua A. Halpern
Joshua A. Halpern
ARAshley E. Ross
Ashley E. Ross
We present the case of an 83-year-old man with metastatic prostate cancer who had testosterone levels reading above castration range despite appropriate medical and surgical castration. Mass spectrometry was performed to confirm presence of testosterone, but no testosterone was detected. The elevated testosterone as measured by standard immunoassay was postulated to be secondary to heterophile antibodies in the patient's serum. This report highlights the need for a high index of suspicion for interference in testosterone immunoassays when levels remain mildly elevated. Mass spectrometry may provide a more reliable method by which to detect testosterone concentration prior to escalation of care.

17 June 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
PDF file
ASArjun Sarkar
Arjun Sarkar
MIMartha-Conley E. Ingram
Martha-Conley E. Ingram
YTYao Tian
Yao Tian
BMBenjamin T. Many
Benjamin T. Many
YRYazan Rizeq
Yazan Rizeq
MRMehul V. Raval
Mehul V. Raval